Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Nationwide Investigation of Extended-Spectrum β-Lactamases, Metallo-β-Lactamases, and Extended-Spectrum Oxacillinases Produced by Ceftazidime-Resistant <italic>Pseudomonas aeruginosa</italic> Strains in France <xref ref-type="fn" rid="fn1">▿</xref> </title><author><name sortKey="Hocquet, Didier" sort="Hocquet, Didier" uniqKey="Hocquet D" first="Didier" last="Hocquet">Didier Hocquet</name><affiliation><nlm:aff id="aff0">Centre National de Référence de la Résistance aux Antibiotiques, Laboratoire associé P. aeruginosa, Hôpital Jean Minjoz, Besançon, France</nlm:aff></affiliation></author><author><name sortKey="Plesiat, Patrick" sort="Plesiat, Patrick" uniqKey="Plesiat P" first="Patrick" last="Plésiat">Patrick Plésiat</name><affiliation><nlm:aff id="aff0">Centre National de Référence de la Résistance aux Antibiotiques, Laboratoire associé P. aeruginosa, Hôpital Jean Minjoz, Besançon, France</nlm:aff></affiliation></author><author><name sortKey="Dehecq, Barbara" sort="Dehecq, Barbara" uniqKey="Dehecq B" first="Barbara" last="Dehecq">Barbara Dehecq</name><affiliation><nlm:aff id="aff0">Centre National de Référence de la Résistance aux Antibiotiques, Laboratoire associé P. aeruginosa, Hôpital Jean Minjoz, Besançon, France</nlm:aff></affiliation></author><author><name sortKey="Mariotte, Pierre" sort="Mariotte, Pierre" uniqKey="Mariotte P" first="Pierre" last="Mariotte">Pierre Mariotte</name><affiliation><nlm:aff id="aff0">Centre National de Référence de la Résistance aux Antibiotiques, Laboratoire associé P. aeruginosa, Hôpital Jean Minjoz, Besançon, France</nlm:aff></affiliation></author><author><name sortKey="Talon, Daniel" sort="Talon, Daniel" uniqKey="Talon D" first="Daniel" last="Talon">Daniel Talon</name><affiliation><nlm:aff id="aff0">Centre National de Référence de la Résistance aux Antibiotiques, Laboratoire associé P. aeruginosa, Hôpital Jean Minjoz, Besançon, France</nlm:aff></affiliation></author><author><name sortKey="Bertrand, Xavier" sort="Bertrand, Xavier" uniqKey="Bertrand X" first="Xavier" last="Bertrand">Xavier Bertrand</name><affiliation><nlm:aff id="aff0">Centre National de Référence de la Résistance aux Antibiotiques, Laboratoire associé P. aeruginosa, Hôpital Jean Minjoz, Besançon, France</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">20547814</idno><idno type="pmc">2916347</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2916347</idno><idno type="RBID">PMC:2916347</idno><idno type="doi">10.1128/AAC.01646-09</idno><date when="2010">2010</date><idno type="wicri:Area/Pmc/Corpus">000176</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Nationwide Investigation of Extended-Spectrum β-Lactamases, Metallo-β-Lactamases, and Extended-Spectrum Oxacillinases Produced by Ceftazidime-Resistant <italic>Pseudomonas aeruginosa</italic> Strains in France <xref ref-type="fn" rid="fn1">▿</xref> </title><author><name sortKey="Hocquet, Didier" sort="Hocquet, Didier" uniqKey="Hocquet D" first="Didier" last="Hocquet">Didier Hocquet</name><affiliation><nlm:aff id="aff0">Centre National de Référence de la Résistance aux Antibiotiques, Laboratoire associé P. aeruginosa, Hôpital Jean Minjoz, Besançon, France</nlm:aff></affiliation></author><author><name sortKey="Plesiat, Patrick" sort="Plesiat, Patrick" uniqKey="Plesiat P" first="Patrick" last="Plésiat">Patrick Plésiat</name><affiliation><nlm:aff id="aff0">Centre National de Référence de la Résistance aux Antibiotiques, Laboratoire associé P. aeruginosa, Hôpital Jean Minjoz, Besançon, France</nlm:aff></affiliation></author><author><name sortKey="Dehecq, Barbara" sort="Dehecq, Barbara" uniqKey="Dehecq B" first="Barbara" last="Dehecq">Barbara Dehecq</name><affiliation><nlm:aff id="aff0">Centre National de Référence de la Résistance aux Antibiotiques, Laboratoire associé P. aeruginosa, Hôpital Jean Minjoz, Besançon, France</nlm:aff></affiliation></author><author><name sortKey="Mariotte, Pierre" sort="Mariotte, Pierre" uniqKey="Mariotte P" first="Pierre" last="Mariotte">Pierre Mariotte</name><affiliation><nlm:aff id="aff0">Centre National de Référence de la Résistance aux Antibiotiques, Laboratoire associé P. aeruginosa, Hôpital Jean Minjoz, Besançon, France</nlm:aff></affiliation></author><author><name sortKey="Talon, Daniel" sort="Talon, Daniel" uniqKey="Talon D" first="Daniel" last="Talon">Daniel Talon</name><affiliation><nlm:aff id="aff0">Centre National de Référence de la Résistance aux Antibiotiques, Laboratoire associé P. aeruginosa, Hôpital Jean Minjoz, Besançon, France</nlm:aff></affiliation></author><author><name sortKey="Bertrand, Xavier" sort="Bertrand, Xavier" uniqKey="Bertrand X" first="Xavier" last="Bertrand">Xavier Bertrand</name><affiliation><nlm:aff id="aff0">Centre National de Référence de la Résistance aux Antibiotiques, Laboratoire associé P. aeruginosa, Hôpital Jean Minjoz, Besançon, France</nlm:aff></affiliation></author></analytic><series><title level="j">Antimicrobial Agents and Chemotherapy</title><idno type="ISSN">0066-4804</idno><idno type="eISSN">1098-6596</idno><imprint><date when="2010">2010</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>A nationwide study aimed to identify the extended-spectrum β-lactamases (ESBLs), metallo-β-lactamases (MBLs), and extended-spectrum oxacillinases (ES-OXAs) in a French collection of 140 clinical <italic>Pseudomonas aeruginosa</italic> isolates highly resistant to ceftazidime. Six ESBLs (PER-1, <italic>n</italic> = 3; SHV-2a, <italic>n</italic> = 2; VEB-1a, <italic>n</italic> = 1), four MBLs (VIM-2, <italic>n</italic> = 3; IMP-18, <italic>n</italic> = 1), and five ES-OXAs (OXA-19, <italic>n</italic> = 4; OXA-28, <italic>n</italic> = 1) were identified in 13 isolates (9.3% of the collection). The prevalence of these enzymes is still low in French clinical <italic>P. aeruginosa</italic> isolates but deserves to be closely monitored.</p></div></front></TEI><pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Antimicrob Agents Chemother</journal-id><journal-id journal-id-type="publisher-id">aac</journal-id><journal-title-group><journal-title>Antimicrobial Agents and Chemotherapy</journal-title></journal-title-group><issn pub-type="ppub">0066-4804</issn><issn pub-type="epub">1098-6596</issn><publisher><publisher-name>American Society for Microbiology (ASM)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">20547814</article-id><article-id pub-id-type="pmc">2916347</article-id><article-id pub-id-type="publisher-id">1646-09</article-id><article-id pub-id-type="doi">10.1128/AAC.01646-09</article-id><article-categories><subj-group subj-group-type="heading"><subject>Mechanisms of Resistance</subject></subj-group></article-categories><title-group><article-title>Nationwide Investigation of Extended-Spectrum β-Lactamases, Metallo-β-Lactamases, and Extended-Spectrum Oxacillinases Produced by Ceftazidime-Resistant <italic>Pseudomonas aeruginosa</italic> Strains in France <xref ref-type="fn" rid="fn1">▿</xref> </article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hocquet</surname><given-names>Didier</given-names></name><xref ref-type="aff" rid="aff0"></xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Plésiat</surname><given-names>Patrick</given-names></name><xref ref-type="aff" rid="aff0"></xref></contrib><contrib contrib-type="author"><name><surname>Dehecq</surname><given-names>Barbara</given-names></name><xref ref-type="aff" rid="aff0"></xref></contrib><contrib contrib-type="author"><name><surname>Mariotte</surname><given-names>Pierre</given-names></name><xref ref-type="aff" rid="aff0"></xref></contrib><contrib contrib-type="author"><name><surname>Talon</surname><given-names>Daniel</given-names></name><xref ref-type="aff" rid="aff0"></xref></contrib><contrib contrib-type="author"><name><surname>Bertrand</surname><given-names>Xavier</given-names></name><xref ref-type="aff" rid="aff0"></xref></contrib><contrib contrib-type="author"><collab>on behalf of ONERBA</collab></contrib></contrib-group><aff id="aff0">Centre National de Référence de la Résistance aux Antibiotiques, Laboratoire associé P. aeruginosa, Hôpital Jean Minjoz, Besançon, France</aff><author-notes><corresp id="cor1"><label>*</label>Corresponding author. Present address: Department of Microbiology, University of Washington, School of Medicine, Seattle, WA 98195. Phone: (206) 616-5107. Fax: (206) 616-5109. E-mail: <email>dhocquet@univ-fcomte.fr</email></corresp></author-notes><pub-date pub-type="ppub"><month>8</month><year>2010</year></pub-date><pub-date pub-type="epub"><day>14</day><month>6</month><year>2010</year></pub-date><volume>54</volume><issue>8</issue><fpage>3512</fpage><lpage>3515</lpage><history><date date-type="received"><day>17</day><month>11</month><year>2009</year></date><date date-type="rev-recd"><day>24</day><month>1</month><year>2010</year></date><date date-type="accepted"><day>29</day><month>5</month><year>2010</year></date></history><permissions><copyright-statement>Copyright © 2010, American Society for Microbiology</copyright-statement><copyright-year>2010</copyright-year></permissions><self-uri xlink:title="pdf" xlink:href="zac00810003512.pdf"></self-uri><abstract><p>A nationwide study aimed to identify the extended-spectrum β-lactamases (ESBLs), metallo-β-lactamases (MBLs), and extended-spectrum oxacillinases (ES-OXAs) in a French collection of 140 clinical <italic>Pseudomonas aeruginosa</italic> isolates highly resistant to ceftazidime. Six ESBLs (PER-1, <italic>n</italic> = 3; SHV-2a, <italic>n</italic> = 2; VEB-1a, <italic>n</italic> = 1), four MBLs (VIM-2, <italic>n</italic> = 3; IMP-18, <italic>n</italic> = 1), and five ES-OXAs (OXA-19, <italic>n</italic> = 4; OXA-28, <italic>n</italic> = 1) were identified in 13 isolates (9.3% of the collection). The prevalence of these enzymes is still low in French clinical <italic>P. aeruginosa</italic> isolates but deserves to be closely monitored.</p></abstract></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/France/explor/LeHavreV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 0001760 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 0001760 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/France
|area= LeHavreV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé=
|texte=
}}
| This area was generated with Dilib version V0.6.25. |  |